Science 37 Statistics
Share Statistics
Science 37 has 6.03M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 6.03M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,172 |
| FTD / Avg. Volume | 7.65% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -18.87 and the forward
PE ratio is null.
Science 37's PEG ratio is
0.19.
| PE Ratio | -18.87 |
| Forward PE | n/a |
| PS Ratio | 13.72 |
| Forward PS | n/a |
| PB Ratio | 9.88 |
| P/FCF Ratio | -8.97 |
| PEG Ratio | 0.19 |
Financial Ratio HistoryEnterprise Valuation
Science 37 has an Enterprise Value (EV) of 855.47M.
| EV / Sales | 12.2 |
| EV / EBITDA | -6.14 |
| EV / EBIT | -11.34 |
| EV / FCF | -7.97 |
Financial Position
The company has a current ratio of 5.45,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.45 |
| Quick Ratio | 5.45 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0.99 |
Financial Efficiency
Return on Equity is -52.36% and Return on Invested Capital is -106.52%.
| Return on Equity | -52.36% |
| Return on Assets | -40.32% |
| Return on Invested Capital | -106.52% |
| Revenue Per Employee | $152,493.48 |
| Profits Per Employee | $-110,843.48 |
| Employee Count | 460 |
| Asset Turnover | 0.55 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -90K |
| Effective Tax Rate | 0.18% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0.56, so Science 37's
price volatility has been higher than the market average.
| Beta | 0.56 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.62 |
| 200-Day Moving Average | 5.86 |
| Relative Strength Index (RSI) | 57.52 |
| Average Volume (20 Days) | 54,556 |
Income Statement
In the last 12 months, Science 37 had revenue of 70.15M
and earned -50.99M
in profits. Earnings per share was -0.44.
| Revenue | 70.15M |
| Gross Profit | 15.87M |
| Operating Income | -105.33M |
| Net Income | -50.99M |
| EBITDA | -139.41M |
| EBIT | -157.35M |
| Earnings Per Share (EPS) | -0.44 |
Full Income StatementBalance Sheet
The company has 108.09M in cash and 1.32M in
debt, giving a net cash position of 106.77M.
| Cash & Cash Equivalents | 108.09M |
| Total Debt | 1.32M |
| Net Cash | 106.77M |
| Retained Earnings | -253.07M |
| Total Assets | 75.73M |
| Working Capital | 57.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -75.44M
and capital expenditures -31.87M, giving a free cash flow of -107.32M.
| Operating Cash Flow | -75.44M |
| Capital Expenditures | -31.87M |
| Free Cash Flow | -107.32M |
| FCF Per Share | -0.93 |
Full Cash Flow StatementMargins
Gross margin is 22.62%, with operating and profit margins of -150.15% and -72.69%.
| Gross Margin | 22.62% |
| Operating Margin | -150.15% |
| Pretax Margin | -72.82% |
| Profit Margin | -72.69% |
| EBITDA Margin | -198.74% |
| EBIT Margin | -150.15% |
| FCF Margin | -152.99% |
